| These results imply that the myb genes can function either as oncogenes or as tumor suppressors in different cellular contexts. | None |
| MYB oncogene amplification in hereditary BRCA1 breast cancer. | breast, |
| Activation of c-MYC and c-MYB proto-oncogenes is associated with decreased apoptosis in tumor colon progression. | colorectal, |
| Activation of c-MYC and c-MYB proto-oncogenes is associated with decreased apoptosis in tumor colon progression. | colorectal, |
| Transformation of chicken myelomonocytic cells by a retrovirus expressing the v-myb oncogene from the long terminal repeats of avian myeloblastosis virus but not Rous sarcoma virus. | sarcoma, |
| Duplication of MYB is an oncogenic event and we suggest that MYB could be a therapeutic target in human T cell acute lymphoblastic leukemia. | leukemia, |
| Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia. | leukemia, |
| Potential tumor suppressor role for the c-Myb oncogene in luminal breast cancer. | breast, |
| c-Myb proto-oncogene has a tumor suppressor role in breast cancer via c-Myb controlled DHRS2 (HEP27) expression. | breast, |
| Evidence of oncogenic activities of MYB in B-chronic lymphocytic leukemia that include its stimulatory role in MIR155HG transcription. | leukemia, |
| Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53. | liver, |
| results identify Myb as a critical mediator of oncogene addiction in acute myeloid leukemia | leukemia, |
| Telomestatin impairs glioma stem cell survival and growth through the disruption of telomeric G-quadruplex and inhibition of the proto-oncogene, c-Myb. | glioma, |
| The MYB oncogene can suppress apoptosis in acute myeloid leukemia cells by transcriptional repression of DRAK2 expression. | leukemia, |
| Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1. | pediatric,glioma, |
| The MYB proto-oncogene suppresses monocytic differentiation of acute myeloid leukemia cells via transcriptional activation of its target gene GFI1. | leukemia, |
| a mutant mouse model demonstrates how c-Myb with p300 is required for oncogene-induced acute myeloid leukemia | leukemia, |
| Molecular mapping of the oncogene MYB and rearrangements in malignant melanoma. | skin, |
| MicroRNA-193b-3p acts as a tumor suppressor by targeting the MYB oncogene in T-cell acute lymphoblastic leukemia. | leukemia, |
| MicroRNA-193b-3p acts as a tumor suppressor by targeting the MYB oncogene in T-cell acute lymphoblastic leukemia. | leukemia, |